ForuMS: Highlights in MS Care from 2022
Released On
May 15, 2023
Expires On
May 15, 2024
Media Type
Internet
Completion Time
75 minutes
Specialty
Neurology, Pharmacy, Primary Care, Radiology
Topic(s)
Mental Health, Multiple Sclerosis, Pharmacology, Radiology, Rehabilitation
This activity is jointly provided by The Consortium of Multiple Sclerosis Centers and Catamount Medical Education.
This activity is supported by an independent educational grant from Novartis Pharmaceuticals Corporation.
Credit Available
- Physicians — maximum of 1.25 AMA PRA Category 1 Credit(s)™
- Nurses — 1.25 NCPD credit (1.25 in the area of pharmacology)
- Pharmacists — 1.25 contact hours (0.125 CEUs) of continuing pharmacy education credit
All other healthcare professionals completing this course will be issued a statement of participation.
Target Audience
This activity is designed to meet the educational needs of neurologists, primary care clinicians, advanced practice clinicians, nurses, rehabilitation specialists, mental health specialists, radiologists, pharmacists, and other clinicians who are part of the team that manages patients with MS.
Program Overview
A 75 minute online enduring activity that reviews important information that was presented at the Consortium of Multiple Sclerosis Centers (CMSC) meeting and other meetings, such as the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS), as well as key updates to MS care that happened in 2022.
Learning Objectives
At the conclusion of this activity, participants should be better able to:
- Review research and advances in the understanding of MS
- Discuss new evidence and data related to the treatment and management of MS
- Integrate the latest evidence from 2022 into the comprehensive, team-based care of people living with MS in 2023
Faculty
Scott Newsome, DO, MSCS, FAAN, FANA
Past President, Consortium of Multiple Sclerosis Centers
Director, Neurosciences Consultation and Infusion Center
Director, Johns Hopkins Neuroimmunology Clinical Fellowship Program
Co-Director, Multiple Sclerosis Experimental Therapeutics Program
Member, Miller-Coulson Academy of Clinical Excellence
John Hopkins University School of Medicine
Accreditation Statement
In support of improving patient care, this activity has been planned and implemented by The Consortium of Multiple Sclerosis Centers (CMSC) and Catamount Medical Education. CMSC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the health care team.
Credit Designation
Physicians
The CMSC designates this enduring activity for a maximum of 1.25 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nurses
The CMSC designates this activity for a maximum of 1.25 NCPD credit (1.25 in the area of pharmacology).
Pharmacists
This knowledge-based activity, UAN JA4008165-9999-23-020-H01-P qualifies for 1.25 contact hours (.125 CEUs) of continuing pharmacy education credit.
All other health care professionals completing this course will be issued a statement of participation.
Disclosures of Conflicts of Interest
In accordance with the Accreditation Council for Continuing Medical Education’s (ACCME) Standards for Integrity and Independence in Continuing Education, CMSC, and Catamount Medical Education require that individuals in a position to control the content of an educational activity disclose all financial relationships with ineligible companies. CMSC and Catamount Medical Education mitigate all conflicts of interest to ensure independence, objectivity, balance, and scientific rigor in all their educational programs. Furthermore, CMSC and Catamount Medical Education seek to verify that all scientific research referred to, reported, or used in a CE activity conforms to the generally accepted standards of experimental design, data collection, and analysis. CMSC and Catamount Medical Education are committed to providing learners with high-quality CE activities that promote improvements in health care and not those of a commercial interest.
- Scott Newsome, DO, MSCS, FAAN, FANA
- Consulting Fees: Biogen IDEC; Bristol Myers Squibb; Genentech; Greenwich Biosciences, LLC; Novartis Pharmaceuticals Corporation; EMD Serono
- Contracted Research: Biogen IDEC; Genentech; Roche
- Lead Principal Investigator: Roche clinical trial
Activity Staff Disclosures
June Halper, MSN, APN-C, MSCN, FAAN, and Laurie Scudder, DNP, NP, served as planners and reviewers and have disclosed no relevant financial relationships.
All other planners, reviewers, staff, or other members of the Continuing Professional Education Committee at The Consortium of Multiple Sclerosis Centers who control content have disclosed no relevant financial relationships.
The planners, reviewers, editors, staff, CE committee, or other members at Catamount Medical Education who control content have disclosed no relevant financial relationships
How to Participate in this Activity and Obtain CE Credit
There are no fees for participating and receiving credit for this activity. During the period that the activity is available for credit, participants must:
- Read the CE information
- Complete the pretest
- View the content
- Complete the posttest and the evaluation form
A score of 75% correct must be achieved on the posttest to successfully complete the activity. If you do not receive a passing score, you will receive a message notifying you that you did not pass the posttest. You may retake the posttest until successful. Upon completion of the evaluation, your certificate will be emailed to you.
This activity is an online enduring material. There are no fees for participating and receiving credit for this activity. Successful completion is achieved by reviewing the CME information, completing the pre-test, viewing the video, studying the educational activity, and completing the posttest and the evaluation form. Upon completion of the evaluation, your certificate will be made available immediately. Click on "View Certificate" and print the certificate for your records.
This activity was originally released on May 15, 2023 and is eligible for credit through May 15, 2024.
Course Viewing Requirements
This site is best viewed with an HTML5 compatible browser. You can visit the independent (3rd-party) site www.whatismybrowser.com to determine if you have the latest version of your browser.
Certain educational activities may require additional software to view multimedia, presentation, or printable versions of their content. That software may be: Adobe Flash, Apple QuickTime, Adobe Acrobat, Microsoft PowerPoint, Windows Media Player, and Real Networks Real One Player.
Our Policy on Privacy
The Consortium of Multiple Sclerosis Centers and Catamount Medical Education, LLC, respect your privacy. All personal information that is provided to Catamount Medical Education, LLC, is protected and will not be sold to a third party for commercial purposes. All personally identifiable information contained in the Catamount Medical Education, LLC, registration databases is treated as confidential and will be used only for the purposes stated in this policy, except where required by law. Catamount Medical Education, LLC, maintains user databases that contain mailing and user profile information as well as a record of the CME activities viewed and the posttest and evaluation results for CE credit. This information is provided to activity collaborators for the purposes of CE recordkeeping. By participating in this activity, you agree that Catamount Medical Education, LLC, has full permission to provide this information.
Catamount Medical Education, LLC, safeguards against the loss, misuse, or alteration of information that we have collected in this activity.
Disclosure of Unlabeled Use
CMSC and Catamount Medical Education require CE faculty (speakers) to disclose to the attendees when products or procedures being discussed are off-label, unlabeled, experimental, and/or investigational (not FDA approved); and any limitations on the information that is presented, such as data that are preliminary or that represent ongoing research, interim analyses, and/or unsupported opinion. Faculty in this activity may discuss information about pharmaceutical agents that is outside of US Food and Drug Administration approved labeling. This information is intended solely for continuing medical education and is not intended to promote off-label use of these medications. If you have questions, contact the medical affairs department of the manufacturer for the most recent prescribing information.
Disclaimer
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
Contact Information
For questions about this activity, please contact Catamount Medical Education at info@catmeded.com.